KROS
Keros Therapeutics Inc
11.60$
-0.7%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 93.3% | 93.9% | 95.3% | 95.1% | 95.3% | 95.6% | 96.8% | 96.8% | 96.8% | 93.3% | 93.1% | 92.8% | |
| 88.2% | 89.5% | 91.1% | 89.2% | 91.6% | 90.9% | 91.8% | 91.2% | 93.4% | 85.0% | 90.1% | 89.6% | |
| 88.2% | 89.5% | 91.1% | 89.2% | 91.6% | 90.9% | 91.8% | 91.2% | 93.4% | 85.0% | 90.1% | 89.6% | |
| 0.3% | 0.3% | 0.4% | 0.3% | 0.3% | 0.7% | 2.5% | 2.3% | 0.7% | 1.9% | 0.9% | 1.0% | |
| 4.7% | 3.8% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| 9.3% | 10.2% | 6.6% | 7.5% | 8.0% | 7.2% | 7.1% | 6.7% | 5.3% | 10.3% | 8.5% | 8.8% | |
| 5.1% | 6.6% | 3.9% | 4.7% | 5.0% | 4.5% | 5.0% | 4.6% | 3.2% | 6.0% | 4.1% | 4.2% | |
| 0.2% | 0.3% | 0.2% | 0.2% | 0.3% | 0.3% | 0.3% | 0.3% | 0.3% | 0.7% | 0.8% | 0.9% | |
| 1.2% | 1.5% | 1.0% | 1.4% | 0.9% | 0.7% | 0.8% | 0.7% | 0.3% | 0.6% | 0.5% | 0.6% | |
| 90.7% | 89.8% | 93.4% | 92.5% | 92.0% | 92.8% | 92.9% | 93.3% | 94.7% | 89.7% | 91.5% | 91.2% | |
| -104.6% | -103.1% | -87.4% | -103.2% | -90.2% | -92.4% | -53.6% | -59.6% | -61.7% | -142.5% | -161.9% | -185.7% | |
| 9.1% | 8.1% | 6.1% | 7.9% | 6.2% | 6.5% | 5.2% | 5.4% | 5.5% | 8.0% | 6.3% | 6.9% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.